LLY

1,023.34

+1.71%↑

JNJ

230.48

+0.46%↑

ABBV

212.01

-0.57%↓

UNH

389.57

-0.81%↓

AZN

187.16

+1.18%↑

LLY

1,023.34

+1.71%↑

JNJ

230.48

+0.46%↑

ABBV

212.01

-0.57%↓

UNH

389.57

-0.81%↓

AZN

187.16

+1.18%↑

LLY

1,023.34

+1.71%↑

JNJ

230.48

+0.46%↑

ABBV

212.01

-0.57%↓

UNH

389.57

-0.81%↓

AZN

187.16

+1.18%↑

LLY

1,023.34

+1.71%↑

JNJ

230.48

+0.46%↑

ABBV

212.01

-0.57%↓

UNH

389.57

-0.81%↓

AZN

187.16

+1.18%↑

LLY

1,023.34

+1.71%↑

JNJ

230.48

+0.46%↑

ABBV

212.01

-0.57%↓

UNH

389.57

-0.81%↓

AZN

187.16

+1.18%↑

Home・Aktien・Stevanato Group SpA

Stevanato Group SpA

Open

BrancheGesundheitswesen

17.64

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

17.18

Max

17.75

Schlüsselkennzahlen
By Trading Economics
Einkommen	-7.9M 39M
Verkäufe	-70M 274M
KGV Branchendurchschnitt	30.153 51.415
EPS	0.13
Gewinnspanne	14.343
Angestellte	6,010
EBITDA	-25M 65M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+46.54% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	4. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	4.9B
Vorheriger Eröffnungskurs	17.64
Vorheriger Schlusskurs	17.64

Nachrichtenstimmung

By Acuity

50%

174 / 345 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

21.56 / 22.61 Unterstützung & Widerstand

Stevanato Group SpA Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

19. Mai 2026, 20:36 UTC

Akquisitionen, Fusionen, Übernahmen

Analog Devices to Buy Empower Semiconductor for $1.5 Billion

19. Mai 2026, 23:47 UTC

Market Talk

Nikkei May Decline as Concerns About Energy, Material Costs Persists -- Market Talk

19. Mai 2026, 23:34 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

19. Mai 2026, 23:28 UTC

Market Talk

Ergebnisse

Global Forex and Fixed Income Roundup: Market Talk

19. Mai 2026, 23:28 UTC

Market Talk

Ergebnisse

F&P Healthcare's Outlook Key for Investors -- Market Talk

19. Mai 2026, 23:10 UTC

Market Talk

Global Equities Roundup: Market Talk

19. Mai 2026, 23:10 UTC

Market Talk

Kiwi Property's Dividend Growth Reliant on Several Factors -- Market Talk

19. Mai 2026, 22:02 UTC

Ergebnisse

ZTO Express (Cayman): Di Xu to Resign From Board

19. Mai 2026, 22:01 UTC

Ergebnisse

ZTO Express (Cayman) 1Q Adj EPS 43c >ZTO

19. Mai 2026, 22:01 UTC

Ergebnisse

ZTO Express (Cayman) 1Q EPS 39c >ZTO

19. Mai 2026, 22:00 UTC

Ergebnisse

ZTO Express (Cayman) 1Q Rev $1.93B >ZTO

19. Mai 2026, 21:37 UTC

Ergebnisse

Cracks Are Starting to Appear in the Chip Stock Rally -- Barrons.com

19. Mai 2026, 21:31 UTC

Akquisitionen, Fusionen, Übernahmen

How NextEra Can Fix Dominion's Strange AI Problem -- Barrons.com

19. Mai 2026, 21:01 UTC

Ergebnisse

Home Depot Beats Earnings Estimates as Shoppers Defy Inflation Fears. The Stock Advances. -- Barrons.com

19. Mai 2026, 20:58 UTC

Ergebnisse

These Stocks Are Today's Movers: CoreWeave, Nvidia, Home Depot, Akamai, Agilysys, Micron, and More -- Barrons.com

19. Mai 2026, 20:46 UTC

Heiße Aktien

Stocks to Watch Recap: ServiceNow, Home Depot, CoreWeave -- WSJ

19. Mai 2026, 20:43 UTC

Market Talk

Canada 30-Year Yield Hits Highest Level Since 2010 -- Market Talk

19. Mai 2026, 20:34 UTC

Ergebnisse

James Hardie Industries Sees FY27 Sales $5.25B-$5.41B >JHX

19. Mai 2026, 20:32 UTC

Ergebnisse

James Hardie Industries: Targeting Pro Forma Adjusted EBITDA Growth of 4% to 8% in FY27 >JHX

19. Mai 2026, 20:32 UTC

Ergebnisse

James Hardie Industries 4Q EPS 5c >JHX

19. Mai 2026, 20:32 UTC

Ergebnisse

James Hardie Industries 4Q Sales $1.4B >JHX

19. Mai 2026, 20:21 UTC

Akquisitionen, Fusionen, Übernahmen

Analog Devices to Buy Empower Semiconductor for $1.5B

19. Mai 2026, 20:18 UTC

Market Talk

Canada CPI Data Has Accounting Quirk Related to Travel Tours -- Market Talk

19. Mai 2026, 20:13 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

19. Mai 2026, 20:13 UTC

Market Talk

'Hard to Square' Canada Rate Hikes Expectations Given Mild Core -- Market Talk

19. Mai 2026, 20:03 UTC

Akquisitionen, Fusionen, Übernahmen

Analog Devices: Deal Further Advances Position as Strategic, System-Level Grid-To-Core Power Partner for Hyperscalers, AI Silicon Developers >ADI

19. Mai 2026, 20:03 UTC

Akquisitionen, Fusionen, Übernahmen

Analog Devices: Phillips Will Continue Leading IVR Technology Efforts as Part of ADI >ADI

19. Mai 2026, 20:02 UTC

Akquisitionen, Fusionen, Übernahmen

Analog Devices Will Acquire Empower in All-Cash Transaction for $1.5 B >ADI

19. Mai 2026, 20:02 UTC

Akquisitionen, Fusionen, Übernahmen

Analog Devices to Acquire Empower Semiconductor, Expanding Its Next-Generation High-Density Power Portfolio for the AI Era

19. Mai 2026, 19:23 UTC

Market Talk

Oil Futures Slip With Market Back on U.S.-Iran Deal Watch -- Market Talk

Peer-Vergleich

Kursveränderung

Stevanato Group SpA Prognose

Kursziel

By TipRanks

46.54% Vorteil

12-Monats-Prognose

Durchschnitt 26.07 USD 46.54%

Hoch 32 USD

Tief 18.28 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Stevanato Group SpA – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

5 ratings

Buy

Halten

Sell

Basierend auf 5 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Stevanato Group SpA – Dist abgegeben haben.

Technischer Score

By Trading Central

21.56 / 22.61Unterstützung & Widerstand

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Stimmung

By Acuity

174 / 345 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.